ClinicalTrialStartPulse: 300+
500 clinicalTrialStartPulse: 300+ are listed from ClinicalTrials.gov (U.S. National Library of Medicine) API v2, dated 2026-09-14 to 2026-11-02; the most frequent is AstraZeneca with 22. Data last updated 2026-11-03; each record links to its official source and a full report.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
Includes: Sponsor, Phase, Conditions, Enrollment, Countries, Event, Posted, official source URL and score · Card, Apple Pay, Google Pay or Link via Stripe
500 records from ClinicalTrials.gov (U.S. National Library of Medicine) API v2, dated 2026-09-14 to 2026-11-02. Most frequent: AstraZeneca (22). Each record links to a full report and the official source.
Last updated 2026-11-03. Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Get new ClinicalTrialStartPulse records by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
- AstraZeneca (22)
- Pfizer (18)
- Merck Sharp & Dohme LLC (14)
- Janssen Research & Development, LLC (14)
- Hoffmann-La Roche (13)
How do I get new clinicalTrialStartPulse: 300+ by email?
Search, filter and export these records, or get alerts when new ones appear.
What are the top clinicalTrialStartPulse: 300+ right now?
| Record | Phase | Conditions | Enrollment |
|---|---|---|---|
| TriGemX Bio, Inc. | Phase 3 | Migraine | 1500 |
| Vertanical GmbH | Phase 3 | Lumbosacral Radiculopathy | 810 |
| Guangzhou Patronus Biotech Co., Ltd. | Phase 3 | Respiratory Syncytial Virus (RSV); Respiratory Syncytial Virus (RSV) Infection; RSV Vaccine | 25000 |
| Merck Sharp & Dohme LLC | Phase 3 | Small Cell Lung Cancer | 564 |
| Keymed Biosciences Co.Ltd | Phase 3 | Multiple Myeloma (MM) | 320 |
| AstraZeneca | Phase 3 | Large B-cell Lymphoma | 1200 |
| Vaxcyte, Inc. | Phase 3 | Pneumococcal Disease | 1390 |
| Genmab | Phase 3 | Head and Neck Squamous Cell Carcinoma | 699 |
| AstraZeneca | Phase 2 | Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer; Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer | 477 |
| Genmab | Phase 3 | Head and Neck Squamous Cell Carcinoma | 621 |
| ArriVent BioPharma, Inc. | Phase 3 | Metastatic Non-Small Cell Lung Cancer; Advanced Non-Small Cell Lung Cancer; EGFR Exon 20 Mutations | 398 |
| Bristol-Myers Squibb | Phase 3 | Urothelial Cancer | 1314 |
| LuciLab | Phase 3 | Risk Behavior; Cognitive Decline | 368 |
| Merck Sharp & Dohme LLC | Phase 3 | Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer | 646 |
| EyeBiotech Ltd. | Phase 3 | Diabetic Macular Edema (DME) | 1054 |
| Viatris Innovation GmbH | 🔒 Unlock all 500 records → | ||
| Viatris Innovation GmbH | 🔒 Unlock all 500 records → | ||
| Janssen Research & Development, LLC | 🔒 Unlock all 500 records → | ||
Browse 35 more matching record reports
- Viatris Innovation GmbH
- Viatris Innovation GmbH
- Janssen Research & Development, LLC
- Qilu Pharmaceutical Co., Ltd.
- Pfizer
- BeiGene
- Merck Sharp & Dohme LLC
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Janssen Research & Development, LLC
- Jade Biosciences, Inc.
- Kite, A Gilead Company
- Hoffmann-La Roche
- Hoffmann-La Roche
- BioNTech SE
- Carmot Therapeutics, Inc.
- Eli Lilly and Company
- Biohaven Therapeutics Ltd.
- Beijing InnoCare Pharma Tech Co., Ltd.
- CytomX Therapeutics
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- AstraZeneca
- AbbVie
- Takeda
- Pelage Pharmaceuticals, Inc.
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Jiangsu HengRui Medicine Co., Ltd.
- Celltrion
- Amgen
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- RemeGen Co., Ltd.
- Jiangsu HengRui Medicine Co., Ltd.
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Shionogi
- Multitude Therapeutics Inc.
- Hoffmann-La Roche
Which related categories and locations should I check?
Browse by phase
Not applicable (device, behavioral) (4211) Observational (1999) Phase 2 (1077) Phase 3 (559) Phase 1 (546) Phase 4 (320) Early phase 1 (89)
Browse by site location
Outside the US only (6377) United States sites (2424)
Browse by minimum enrollment
100+ (326) 50+ (283) 1,000+ (54)
Frequently asked questions
How many clinicalTrialStartPulse: 300+ are listed?
500 records from ClinicalTrials.gov (U.S. National Library of Medicine) API v2, last refreshed automatically. The most recent is dated 2026-11-02.
Can I get alerts for 300+?
Yes. ClinicalTrialStartPulse can email you new records matching this filter; plans are listed on the ClinicalTrialStartPulse page.
Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2. Informational only. RSS feed of new records